Click Therapeutics, Medical Clinic, New York, USA
VerifiedAbout This Business
Click Therapeutics, Inc. is at the forefront of integrating software into medical treatments. Founded in 2012 by David Benshoof Klein, the company has developed a platform that combines neuroscience with technology to create Digital Therapeutics™—software applications prescribed by physicians to treat various medical conditions.
Mission and Vision
Click's mission is to provide patients with access to safe and effective digital treatments, aiming to bridge gaps in traditional healthcare by offering scalable and personalized interventions. The company's vision is to redefine modern medicine by delivering software-based treatments that can be prescribed alongside or instead of conventional therapies.
Product Portfolio
-
CT-101 (Clickotine™): A prescription digital therapeutic designed to aid in smoking cessation. It combines behavioral therapy with neuromodulatory techniques to help users quit smoking.
-
CT-132: An investigational digital therapeutic aimed at preventing episodic migraines. It recently met its primary endpoint in the ReMMi-D pivotal trial, demonstrating a reduction in monthly migraine days.
-
CT-155: Developed in collaboration with Boehringer Ingelheim, this digital therapeutic targets the negative symptoms of schizophrenia. It has received FDA Breakthrough Device designation and is undergoing a pivotal clinical trial.
-
CT-102: In partnership with Indivior, Click is developing this digital therapeutic to treat Opioid Use Disorder. It combines evidence-based behavioral therapy with personalized neuromodulatory interventions.
Click SE™: Software-Enhanced Drugs
Click has introduced Click SE™, a novel approach that combines pharmacotherapy with digital therapeutics. This integration aims to enhance the clinical benefits of medications by providing personalized, software-driven interventions alongside traditional drug treatments. The FDA is currently considering draft guidance on Prescription Drug-Use Related Software (PDURS), which could pave the way for such integrated therapies to be prescribed together.